Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03606460
Brief Title: A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)

First Submitted : July 23, 2018
First Submitted that Met QC Criteria : July 23, 2018
First Posted : July 30, 2018

Results First Submitted : May 12, 2020
Results First Submitted that Met QC Criteria : June 12, 2020
Results First Posted : June 29, 2020

Last Update Submitted that Met QC Criteria : June 12, 2020
Last Update Posted : June 29, 2020